http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108409587-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_80fdaa0d94f29478467816f48d47639e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C227-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C227-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C229-60
filingDate 2017-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0be20f0f2cd2cfe19a93a631f8c6ee8b
publicationDate 2018-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-108409587-A
titleOfInvention A kind of synthetic method of pharmaceutical intermediate gavaculine
abstract A kind of synthetic method of pharmaceutical intermediate gavaculine, mainly includes the following steps:The stannous chloride of 3mol, the toluene solution of 4-5mol, the m-Nitrobenzoic Acid solution of 5mol are added in the reaction vessel, solution temperature is increased to 60-70 DEG C, controls 110-130rpm of mixing speed, keeps 90-110min, pH value of solution is adjusted to 9 10 with sodium hydroxide solution, is reduced solution temperature to 5-10 DEG C, is precipitated crystal, the washing of 6L ethanol solutions is added, sodium chloride solution washs, nitromethane solution washing, ethylenediamine solution washing, dehydrating agent is dehydrated, and obtains finished product gavaculine.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112358409-A
priorityDate 2017-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61436
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419518119
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3301
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549866
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8497
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559368
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448277656
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448924711
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451816491
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410994934
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69267
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456922693
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6375
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1140
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24436

Total number of triples: 34.